Icon

LUCEMYRA (nda209229)- (EQ 0.18MG BASE)

LOFEXIDINE HYDROCHLORIDE USWM
EQ 0.18MG BASE
No No
Expired 2023-May-16
None None
None No
LUCEMYRA is a central alpha-2 adrenergic agonist indicated for mitigation of opioid withdrawal symptoms to facilitate abrupt opioid discontinuation in adults.
1 0 1
Total Other Developers 5
Drugs with Suitability No
EQ 0.18MG BASE ** ** - - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ****** ****** ******** ******* *********** *** *****-** & ***, *-**,**,**, ***** ********** ****, *****, ***, *** ******, ***** (***) ***
****** ****** ****** ******** ******* *********** *** *****-*, *-**, ***** ********** ****, *****, ***, *** ******, ***** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.